ADVFN US – Market Content Editor
-
Altimmune shares climb after first-quarter loss beats expectations (ALT)
Shares of Altimmune (NASDAQ:ALT) rose more than 3% in premarket trading on Wednesday after the company reported a smaller-than-expected first-quarter loss. The stock gained 3.57% following the earnings release. Quarterly loss comes in ahead of forecasts Altimmune posted a first-quarter loss of -$0.18 per share, outperforming analyst expectations for a loss of -$0.24 per share.…
-
US producer inflation accelerates sharply in April, exceeding forecasts
Following the release of U.S. consumer inflation figures a day earlier, new data published Wednesday by the Labor Department showed producer prices rose far more than expected in April, adding to concerns about persistent inflationary pressures. The Labor Department said its producer price index for final demand increased 1.4% in April after March’s gain was…
-
Wall Street futures signal mixed start as inflation concerns offset tech strength: Dow Jones, S&P, Nasdaq
U.S. stock futures pointed to a mixed open on Wednesday, with investors balancing renewed strength in technology shares against fresh inflation data that reinforced concerns about interest rates and rising costs. Futures tied to the Nasdaq moved higher ahead of the open, supported by gains in semiconductor stocks, while broader market sentiment outside the technology…
-
Atour Lifestyle tops forecasts as quarterly revenue jumps 47.5% (ATAT)
Atour Lifestyle Holdings (NASDAQ:ATAT) reported first-quarter 2026 results on Wednesday that came in ahead of analyst expectations, supported by strong growth across its hotel and retail operations. Shares of the company slipped 0.68% in premarket trading following the earnings release. Revenue and profit post strong year-on-year growth Quarterly revenue increased 47.5% year-on-year to RMB2.81 billion…
-
Paysafe tops quarterly expectations while shares stay muted after guidance update (PSFE)
Paysafe (NYSE:PSFE) reported first-quarter results on Wednesday that came in ahead of Wall Street forecasts, while the company also reaffirmed its full-year outlook. Despite the earnings beat, shares slipped 0.46% in premarket trading following the announcement. Revenue and adjusted earnings exceed forecasts Paysafe posted adjusted earnings per share of $0.41 for the quarter, outperforming analyst…
-
Riskified shares surge after company raises full-year outlook despite earnings miss (RSKD)
Shares of Riskified (NYSE:RSKD) jumped more than 9% in premarket trading on Wednesday after the company lifted its full-year guidance, even though first-quarter earnings fell short of analyst expectations. Revenue tops forecasts while earnings disappoint Riskified reported a first-quarter loss of $0.03 per share for the period ended March 31, missing analyst forecasts for a…
-
Kornit Digital tops revenue and earnings expectations in first quarter (KRNT)
Kornit Digital (NASDAQ:KRNT) reported first-quarter results on Wednesday that exceeded Wall Street expectations on both revenue and earnings, although the company’s shares slipped slightly in after-hours trading following the announcement. The stock edged down 0.44% after the results were released. Revenue and earnings come in ahead of forecasts Kornit posted adjusted earnings per share of…
-
Caesarstone tops earnings forecasts while revenue misses expectations (CSTE)
Caesarstone (NASDAQ:CSTE) reported first-quarter results on Wednesday that came in ahead of analyst expectations on earnings, although revenue fell short as the company continued restructuring operations in a difficult market environment. The company’s shares showed little movement in after-hours trading following the earnings release. Revenue declines amid softer global demand Caesarstone posted an adjusted loss…
-
Compass Pathways jumps after earnings beat and accelerated FDA review progress (CMPS)
Shares of Compass Pathways (NASDAQ:CMPS) climbed nearly 8% in premarket trading on Wednesday after the company reported first-quarter results that exceeded analyst expectations and highlighted important regulatory advances for its COMP360 psilocybin-based treatment. Earnings outperform as company advances toward approval Compass Pathways posted adjusted earnings per share of -$0.30 for the quarter, beating analyst forecasts…
-
Valens Semiconductor tops earnings forecasts but revenue comes in light (VLN)
Valens Semiconductor (NYSE:VLN) reported first-quarter results on Wednesday that beat analyst expectations on earnings but fell short on revenue, while the company also issued softer-than-expected guidance for the current quarter. Shares edged up 0.37% in premarket trading following the earnings release. Earnings outperform despite revenue miss The connectivity chipmaker posted an adjusted loss of $0.05…